Adenine nucleotide translocator 2 (ANT2) (ANT2)

Adenine nucleotide translocator 2 (ANT2), encoded by the SLC25A5 gene, is a vital mitochondrial membrane protein that facilitates the exchange of ADP and ATP between the mitochondrial matrix and the cytosol [1]. In osteoclasts, ANT2 is significantly upregulated during differentiation, providing the high levels of ATP required for bone resorption and the maintenance of the acidic microenvironment necessary for mineral dissolution [2][3]. Research indicates that ANT2 is essential for the metabolic reprogramming that occurs during osteoclastogenesis, specifically supporting oxidative phosphorylation and cellular energy homeostasis [3]. Beyond its role in energy metabolism, ANT2 is a structural component of the mitochondrial permeability transition pore (mPTP), making it a key regulator of apoptosis and cell survival [4]. Targeting ANT2 in osteoclasts presents a potential therapeutic strategy for metabolic bone diseases like osteoporosis, as its inhibition can suppress osteoclast maturation and activity [3][5]. However, because ANT isoforms are ubiquitously expressed and essential for cellular energetics, achieving tissue-specific inhibition remains a significant challenge to avoid systemic toxicity [1][6].

Other names

ADP/ATP translocase 2Solute carrier family 25 member 5SLC25A5Adenine nucleotide carrier 2ANT 2ADP/ATP carrier protein 2

Inhibition of the exchange of mitochondrial ATP for cytosolic ADP, which depletes the energy required for osteoclast-mediated bone resorption and induces apoptosis by modulating the mitochondrial permeability transition pore [2][4].